Mode
Text Size
Log in / Sign up

FRMPD4 gene variants associated with prelingual hearing loss in two families, cross-species studies show

FRMPD4 gene variants associated with prelingual hearing loss in two families, cross-species studies …
Photo by Logan Voss / Unsplash
Key Takeaway
Consider FRMPD4 in genetic panels for congenital hearing loss, but recognize evidence is from a small familial association.

This study combined human genetic analysis with cross-species functional characterization. Researchers identified maternally inherited missense variants in the FRMPD4 gene in three affected males from two unrelated families with non-syndromic sensorineural hearing loss. The human phenotype was characterized as prelingual, bilaterally symmetrical hearing loss, with congenital onset confirmed in one individual. No neurodevelopmental abnormalities were reported in these cases.

Functional studies were conducted across multiple species. In Drosophila, FRMPD4 homolog mutants showed impaired auditory function. In zebrafish, FRMPD4 knockdown led to reduced neuronal populations in the otic vesicle and posterior lateral line, abnormal neuromast development, and diminished acoustic startle responses. In mice, Frmpd4 knockout resulted in high-frequency hearing loss and cochlear abnormalities.

Safety and tolerability data were not reported for the human subjects. The study's key limitations include a very small human sample size of only three affected males from two families. The findings, while providing strong cross-species evidence for FRMPD4's role in auditory function, demonstrate an association rather than definitive proof of causation in humans. The practice relevance lies in potentially expanding the genetic diagnostic panel for patients with congenital hearing loss, but clinical application requires validation in larger cohorts.

Study Details

EvidenceLevel 5
PublishedMar 2026
View Original Abstract ↓
BackgroundUnderstanding the phenotypic spectrum of disease-associated genes is essential for accurate diagnosis and targeted therapy. FRMPD4 (FERM and PDZ Domain Containing 4) has previously been associated with intellectual disability and epilepsy. However, its potential role in non-syndromic hearing loss has not been explored. MethodsWe performed genetic analysis in two unrelated families presenting with non-syndromic sensorineural hearing loss, identifying maternally inherited missense variants in FRMPD4. Clinical phenotyping included audiological assessment and evaluation for neurodevelopmental involvement. Cross-species expression analyses were conducted in Drosophila, zebrafish, and mouse. Functional characterization included quantitative evaluation of sound-evoked responses in Drosophila nicht gut horend (ngh) mutants, assessment of neuronal development and acoustic startle responses in zebrafish loss of function models, and morphological cochlear analyses with auditory brainstem response measurements in knockout mice. ResultsThree affected males from two unrelated families presented with prelingual, bilaterally symmetrical sensorineural hearing loss, with confirmed congenital onset in one individual and no evidence of neurodevelopmental abnormalities. Cross-species analyses demonstrated evolutionarily conserved expression of FRMPD4 in auditory structures. In Drosophila, quantitative analysis of sound-evoked responses in ngh mutants revealed impaired auditory function. Zebrafish loss of function models exhibited reduced neuronal populations in the otic vesicle and posterior lateral line, abnormal neuromast development, and diminished acoustic startle responses. In mice, Frmpd4 knockout resulted in high-frequency hearing loss and cochlear abnormalities consistent with the human phenotype. ConclusionsOur findings expand the phenotypic spectrum of FRMPD4 to include non-syndromic sensorineural hearing loss and establish its evolutionarily conserved role in auditory function. These results have direct implications for genetic diagnosis and variant interpretation in patients with hearing loss.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.